Leonide Saad

Leonide Saad

Company: Alkeus Pharmaceuticals, Inc.

Job title: President & CEO

Seminars:

Panel Discussion: Developing, Commercializing & Delivering Dry AMD Therapeutics into the Hands of Physicians & Patients in Need 3:30 pm

During this discussion we will summarise the learnings of the meeting by addressing: Strengths What are the strengths of existing dry AMD therapeutic approaches? Opportunities What is the marketing opportunity versus unmet patient clinical need that needs to be addressed by emerging therapeutic approaches for dry AMD? As we are working outside of an orphan…Read more

day: Day Two

Live Presenter Q&A 9:40 am

Read more

day: Day Two

Slow Progression of Dry AMD: Small Molecule Approaches 9:00 am

• Dry AMD treatment with minerals, antioxidants, and other natural compounds. • Current challenges and therapeutic approaches for the treatment of Geographic Atrophy: drug delivery, animal models, study designs • Visual cycle: to slow or not to slow? Use of ALK-001 as vitamin A replacement therapy for the treatment of dry-AMD or Geographic AtrophyRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.